Beta defensins are a family of mammalian defensins. The beta defensins are antimicrobial peptides implicated in the resistance of epithelial surfaces to microbial colonization. Defensins are 2-6 kDa, cationic, microbicidal peptides active against many Gram-negative and Gram-positive bacteria, fungi, and enveloped viruses, containing three pairs of intramolecular disulfide bonds. On the basis of their size and pattern of disulfide bonding, mammalian defensins are classified into alpha, beta and theta categories. Every mammalian species explored thus far has beta-defensins. In cows, as many as 13 beta-defensins exist in neutrophils. However, in other species, beta-defensins are more often produced by epithelial cells lining various organs (e.g. the epidermis, bronchial tree and genitourinary tract.
Novozymes Adenium Biotech A/S
Novozymes A/S
http://www.novozymes.com
|
Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.
Enzyme
Medicine
Industrial enzymes
Biopolymer
Microorganism
Protease
Lipase
Raw material
Feed additive
Soil treatment
Amylase
Pesticide
Cellulase
Seed treatment
Biopesticide
Animal nutrition
Fungicide
Preservative
Yeast
Bioherbicide
AgGenetics, Inc.
http://www.aggenetics.com
|
Global demand for protein will double in the next few decades. The only way to meet this demand in a way that is both respectful of animal well being and preserves or increases wild spaces is to make livestock that are better adapted to their environment, and which use fewer resources to produce the same amount of protein. In this way, their solutions can help the livestock, the planet, and the producer, all at the same time.
See the video presentation or the links below for an overview of their current projects.
Livestock
Biotechnology
Gene
Botany
Agriculture
Medicine
Pharmacy
Fishery
Oceanography
Chemistry
Nanotechnology
Biology
Defensin Therapeutics ApS
https://www.defensintherapeutics.com
|
Defensin Therapeutics ApS
Phigenix Pharmaceuticals
https://www.phigenix.com
|
Headquartered in Atlanta, Georgia, PHIGENIX, Inc. will leverage licensed patented technology to establish a strong first-mover advantage in Personalized Medicine and forge a lasting leadership position in the rapidly evolving cancer diagnostic and therapeutics industry. The PHIGENIX technology platform involves detecting and targeting the PAX2 and EN2 oncogenes for cancer diagnosis and treatment.
We are currently developing diagnostic tests which may detect prostate abnormalities at the pre-malignant state years before the onset of cancer. Our therapeutics in development involves blocking the expression of cancer causing proteins and the subsequent re-expression of a naturally occurring component of the immune system to fight cancer. Finally, we are developing novel drugs, antibodies and antibody-drug conjugates to deactivate the cancer causing protein for cancer treatment and/or prevention.
Cancer
Personalized medicine
PAX2
Oncogene
Abnormality
Prostate
Immune system
Diagnostic test
Antibody
Drug
ZymoGenetics, Inc.
http://www.zymogenetics.com
|
ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.
Medicine
Pharmacy and Therapeutics
Protein chemistry
Therapeutic protein
Bevacizumab
Regulatory affairs
Process development
Antibody
Thalidomide
Lenalidomide
Pembrolizumab
Blinatumomab
Drug
Cancer immunotherapy
Immunotherapy
Monoclonal antibody
Oncology drugs
Clinical trial
Ligation clip
Wound healing
IPF PharmaCeuticals GmbH
http://www.ipf-pharmaceuticals.de
|
Engages in renting and leasing of commercial land & non-residential buildings
Marketing authorization
Orphan drug
Drug development
Drug discovery
Otsuka Pharmaceutical Co., Ltd.
Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.
Nutraceutical
Cosmetics
Drug
Medicine
Food products
Syringe
Bodybuilding supplement
Ethambutol
Pyrazinamide
Sports nutrition
Antithrombotic
Oncology drugs
Anticoagulant
Sewing needle
Protein bar
Prebiotic
Injector
Astaxanthin
Yves Saint Laurent Parfums Corp.
Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. Its products include vegetable cells, peptides, biomolecule, natural extract, and others. The company was founded on November 11, 2005 and is headquartered in Incheon, South Korea.
Medical equipment
Medicine
Biomolecule
Peptide
Cell
Management Co., part of McKesson Corp., is a company headquartered in Richmond, VA. The firm provides medical billing services. On March 18, 1992 Per-Se Technologies, Inc. acquired Management Co.
University of Iowa Research Foundation
http://research.uiowa.edu/uirf
|
The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.
Gene delivery
Expression vector
Viral vector
Plasmid
Cell therapy
Genome
Genomics
Gene silencing
Dendritic cell
Cell sorting
Biochip
Transfection
Flow cytometry
Cell culture
Biomedical engineering
Optoelectronics
Biobank
Microfluidics
Blood cell
Cell signaling
BASF Beauty Care Solutions France SAS
BASF Beauty Care Solutions France SAS, a subsidiary of BASF SE, is a company headquartered in Lyon, France. The firm operates as a chemical company. It was founded in 1985. Patrick Ledjam is the CEO, in this role since 2013.
Snow Brand Milk Products Co., Ltd.
http://www.snowbrand.co.jp
|
Estabished in1950, Snow Brand Milk Products Co. Ltd. is a Japanese dairy company that manufactures cheese, butter, milk and other dairy products. They also manufacture fruit juices and frozen desserts and offers home milk delivery service. Snow Brand has several offices and factories around Japan.
Milk products
Food industry
Raw milk
Pierre Fabre Dermatologie SAS
Pierre Fabre Dermatologie SAS manufactures and markets products for skin diseases. It manages dermatological skin diseases such as acne. The company was founded in September 30, 1996 and is headquartered in Boulogne-Billancourt, France.
Medicine
Clinical trial
Biomedicine
Biotechnology
Mycosis
Dermatological diseases
Atopic dermatitis
Psoriasis
Yeda Research & Development Co. Ltd.
Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education.
- Identify and assess research projects with commercial potential.
- Protect the intellectual property of the Institute and its scientists.
- Create business relationships and license the Institute’s inventions and technologies to the industry.
- Channel funding from industry to research projects.
For further information please contact Tamir Huberman, CIO and Head of Marketing
Association (object-oriented programming)
Intellectual property
Biotechnology
Basic research
Biopharmaceutical
Biomedicine
Microbiome
Dementia
Immunotherapy
Biophysics
Oncology drugs
Clinical trial
Croda International Plc engages in the manufacture and sale of specialty chemicals. It operates through the following business segments: Consumer Care, Life Sciences, and Industrial Specialties. The Consumer Care segment offers specialty sustainable skin care, hair care, and solar protection ingredients. The Life Sciences segment includes crop care and healthcare specialty ingredients. The Industrial Chemicals segment focuses on its biosurfactant plant at Atlas Point in North America. The company was founded by George Crowe and Henry James Dawe on May 25, 1925 and is headquartered in Goole, the United Kingdom.
Chemical engineering
Material Design
Speciality chemicals
Circular economy
Skin care
Lubricant
Crop
Cosmetics
Nutraceutical
Plasticizer
Phase-change material
Eicosapentaenoic acid
Excipient
Krill oil
Drilling fluid
Silicone
Fungicide
Gear oil
Seed treatment
Konkuk University Industry-Academic Cooperation Foundation
https://research.konkuk.ac.kr
|
Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.
YSL Beaute SAS manufactures perfume and beauty products. The company was founded in 2001 and is headquartered in Paris, France.
People also interested in
Chemical engineeringBiophysicsBiomedicineCircular economyClinical trialCell therapyRaw milkDiagnostic testMaterial DesignBiomedical engineering